Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Avalo Therapeutics
(AVTX) Q3 2024
Earnings
AVTX
Aug 12
Confirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
-141
-94.04
-47.07
-0.11
Details
Expected EPS
-6.7
Actual EPS
-14.07
Surprise EPS
-7.37
Surprise Percent
-110%
Description
Avalo Therapeutics (AVTX) has reported earnings of -14.07 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login